Anas Shamsi

Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

Mohsen Naghavi, Kevin S Ikuta, Lucien R Swetschinski et al. · The Lancet · 2024 · 2.2K citations · Full text

Global Burden, Antimicrobial Susceptibility, Antimicrobial Stewardship +12

Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Valery L. Feigin, Melsew Dagne Abate, Yohannes Habtegiorgis Abate et al. · The Lancet Neurology · 2024 · 842 citations · Full text

National Burden, Cerebrovascular Disease, Health Studies +16

Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy

Anas Shamsi, Taj Mohammad, Saleha Anwar et al. · Bioscience Reports · 2020 · 174 citations · Full text

Immunology, Covid-19 Epidemiology, Viral Structural Protein +18

Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies

Taj Mohammad, Shiza Siddiqui, Anas Shamsi et al. · Molecules · 2020 · 156 citations · Full text

Molecular Docking, Medicinal Chemistry, Drug Target +14

Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition

Saleha Anwar, Anas Shamsi, Mohd Shahbaaz et al. · Scientific Reports · 2020 · 155 citations · Full text